Salesforce Announces First Quarter Fiscal 2025 Results

salesforce.com (CRM) PT Raised to $234 at Bernstein SocGen Group

Bernstein SocGen Group analyst Mark Moerdler raised the price target on salesforce.com (NYSE: CRM) to $234.00 (from $231.00) while maintaining a Underperform rating.

The analyst comments "Salesforce had a difficult quarter with misses in revenue, margins, and leading indicators like cRPO, a weak Q2... More

salesforce.com (CRM) PT Lowered to $320 at Morgan Stanley

Morgan Stanley analyst Keith Weiss lowered the price target on salesforce.com (NYSE: CRM) to $320.00 (from $350.00) while maintaining a Overweight rating.

The analyst comments "Weak bookings in Q1 further test investor patience as the GenAI innovation cycle has yet to inflect top-line... More

salesforce.com (CRM) PT Lowered to $250 at Wells Fargo

Wells Fargo analyst Michael Turrin lowered the price target on salesforce.com (NYSE: CRM) to $250.00 (from $300.00) while maintaining a Equal Weight rating.

The analyst comments "FQ1 Results: (1) FQ1 top-line results were below St ests, w/total rev +11% in CC, driven by Sales & Service... More

salesforce.com (CRM) PT Lowered to $260 at Citi

Citi analyst Tyler Radke lowered the price target on salesforce.com (NYSE: CRM) to $260.00 (from $323.00) while maintaining a Neutral rating.

The analyst comments "Macro headwinds returned with a vengeance with an alarming ~150bps shortfall on adj. cRPO in 1Q25 (worst miss we can... More

salesforce.com (CRM) PT Lowered to $315 at Goldman Sachs

Goldman Sachs analyst Kash Rangan lowered the price target on salesforce.com (NYSE: CRM) to $315.00 (from $345.00) while maintaining a Buy rating.

The analyst comments "We reiterate our Buy rating though lower our PT to $315 ($345 prior) after CRMs F1Q25 results largely came in lower than investors expectations. With subscription revenue growth of 12.3% and OPM of 32.1% coming in-line with expectations, cRPO growth of 9.5% 150bps weaker than... More

salesforce.com (CRM) PT Lowered to $300 at Evercore ISI

Evercore ISI analyst Kirk Materne lowered the price target on salesforce.com (NYSE: CRM) to $300.00 (from $330.00) while maintaining a Outperform rating.

The analyst comments "Sort of a messy quarter as revenue came in on the lower end of the guide and bookings were light based on a tougher macro and some GTM changes that impacted execution. Given the uneven macro backdrop, the bigger question coming away from the quarter is whether the top line guide is conservative enough and that concern is pressuring shares in the after-market. While... More

salesforce.com (CRM) PT Lowered to $230 at DA Davidson

DA Davidson analyst Gil Luria lowered the price target on salesforce.com (NYSE: CRM) to $230.00 (from $300.00) while maintaining a Neutral rating.

The analyst comments "Salesforce reported softer than expected 1Q results following a strong 4Q as booking momentum stalled and macro headwinds persisted.... More

Salesforce (CRM) Tops Q1 EPS by 7c, Offers Guidance

Salesforce (NYSE: CRM) reported Q1 EPS of $2.44, $0.07 better than the analyst estimate of $2.37. Revenue for the quarter came in at $9.13 billion versus the consensus estimate of $9.15 billion.

GUIDANCE:

Salesforce sees Q2 2025 EPS of $2.34-$2.36, versus the consensus of $2.40. Salesforce sees Q2... More